Malouf syndrome
ORPHA: 2229
Overview
This syndrome is characterized by the association of dilated cardiomyopathy and hypergonadotropic hypogonadism (DCM-HH)
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Malouf syndrome, sourced from HPO and Orphanet clinical annotations.
Polycystic ovariesWide nasal bridgePtosisHypergonadotropic hypogonadismPrecocious pubertyDilated cardiomyopathyAplasia of the phalanges of the 3rd toe
Classification & Codes
Orphanet Code
ORPHA:2229Malouf syndrome
| Orphanet | ORPHA:2229 |
| Treatments | 0 drug(s) |
| Symptoms on record | 7 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO